Souhaitez-vous accéder aux communiqués récents ?

CHICAGO, April 30, 2025 (GLOBE NEWSWIRE) -- Dresner Partners, an award-winning, FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it...

Aeroflow’s Comprehensive Diabetes Management Program is built to streamline the diabetes management process for both patients and providers.

HENDERSON, Nev., April 15, 2025 (GLOBE NEWSWIRE) -- The Nevada Department of Health and Human Services Division of Health Care Financing and Policy has awarded CareSource, a nationally-recognized,...

AscellaHealth Highlights Rare Disease Capabilities and End-to-End Specialty Pharmaceutical Solutions at World Orphan Drug Congress USA 2025

AscellaHealth Releases Q1 2025 Specialty & Rare Pipeline Digest™ Providing Essential Clinical Drug Updates

DAYTON, Ohio and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- CareSource, a nationally recognized nonprofit managed care organization, today announced that it will seek an affiliation with...

Optime Care has expanded partnership with Eton Pharmaceuticals to serve as the SP provider for GALZIN®, an FDA-approved treatment for Wilson Disease.

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Obesity in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2031" report has been added to ...

Dublin, Feb. 28, 2025 (GLOBE NEWSWIRE) -- The "Medical Billing Services in the United States and Canada" report has been added to ResearchAndMarkets.com's offering.As a leader in industry-specific...

AscellaHealth announces the appointment of two senior leaders: Clayton Edwards, RPh, MBA and Carl T. Bertram, PharmD, MS, MBA